What are the risks and benefits of penicillin (Penicillin G) administration for a pregnant patient who is Group B Streptococcus (GBS) positive during labor?

Penicillin Administration for GBS During Labor

Intrapartum penicillin G prophylaxis for GBS-positive pregnant women is highly effective and strongly recommended, reducing early-onset neonatal GBS disease by 78-80% when administered ≥4 hours before delivery, with minimal maternal risks beyond rare anaphylaxis (approximately 5 per 10,000 treatments). 1, 2, 3, 4

Benefits of Intrapartum Penicillin Prophylaxis

Dramatic Reduction in Neonatal Disease

• Intrapartum antibiotic prophylaxis reduces early-onset GBS disease from 4.7% to 0.4% in colonized mothers (p=0.02), representing a greater than 80% reduction in disease incidence from 1.8 cases per 1,000 live births in the early 1990s to 0.26 cases per 1,000 live births in 2010. 3, 4
• Over 70,000 cases of early-onset GBS invasive disease were prevented in the United States between 1994 and 2010 through implementation of universal screening and prophylaxis strategies. 4
• Effectiveness remains high in both term (91%) and preterm (86%) infants when first-line therapy is received for at least 4 hours before delivery. 4

Pharmacokinetic Advantages

• Penicillin G achieves fetal serum levels 10-179 fold above the minimal inhibitory concentration (MIC) for GBS (0.1 micrograms/mL), even with short durations of prophylaxis. 5
• All fetuses exposed to penicillin G prophylaxis, regardless of duration, achieved levels significantly above the MIC for GBS. 5
• Fetal penicillin G levels increase linearly until 1 hour after administration, then decrease according to a power-decay model, but remain therapeutic throughout the dosing interval. 5

Optimal Timing and Dosing

• Penicillin G 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours until delivery is the preferred regimen endorsed by CDC, ACOG, AAP, ACNM, AAFP, and ASM. 1, 6, 7
• Administration at least 4 hours before delivery provides maximum effectiveness, though even shorter durations achieve therapeutic levels. 2, 5

Risks of Intrapartum Penicillin Prophylaxis

Maternal Risks

Anaphylaxis (Primary Concern)

• The greatest risk is anaphylactic reaction, occurring in approximately 5 cases per 10,000 treatments, which can have severe consequences for both mother and child. 3
• Penicillin should be used with caution in individuals with histories of significant allergies and/or asthma. 8
• The risk of anaphylaxis must be minimized by choosing prophylactic antibiotics based on maternal allergy history, and avoiding antibiotic prophylaxis altogether if the mother has a history of anaphylaxis, whatever the cause. 3

Electrolyte Imbalance

• High doses of penicillin G sodium (above 10 million units) should be administered slowly due to potential adverse effects from electrolyte imbalance, as penicillin G sodium contains 1.68 mEq of sodium per million units. 8

Superinfection

• Antibiotic use may promote overgrowth of nonsusceptible organisms, including fungi, particularly with indwelling intravenous catheters. 8

Neonatal Considerations

• The possible long-term adverse effects of antibiotic exposure during delivery are poorly documented in children. 3
• Implementation of GBS prevention strategies has not resulted in increased use of health services for neonates in most circumstances, and in some cases has decreased the proportion of neonates receiving laboratory evaluations. 2
• Intrapartum antibiotic prophylaxis does not change the clinical spectrum of neonatal illness or delay the onset of clinical signs among infants who contract GBS disease despite prophylaxis. 2

Drug Interactions

• Bacteriostatic antibacterials (chloramphenicol, erythromycins, sulfonamides, tetracyclines) may antagonize the bactericidal effect of penicillin and should be avoided concurrently. 8
• Probenecid and other drugs (aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide diuretics, furosemide, ethacrynic acid) may prolong penicillin blood levels by competing for renal tubular secretion. 8

Alternative Regimens for Penicillin Allergy

Non-High-Risk Allergy

• Cefazolin 2 g IV initially, then 1 g IV every 8 hours until delivery is the preferred alternative for women without high-risk allergy symptoms, as approximately 10% cross-reactivity exists between penicillin and cephalosporins. 1, 6, 7

High-Risk Allergy (History of Anaphylaxis, Angioedema, Urticaria, or Respiratory Distress)

• Clindamycin 900 mg IV every 8 hours until delivery if the GBS isolate is confirmed susceptible to both clindamycin and erythromycin. 1, 6, 7, 9
• Vancomycin 1 g IV every 12 hours until delivery if susceptibility is unknown or the isolate is resistant to clindamycin. 1, 6, 7, 9
• Susceptibility testing for clindamycin and erythromycin must be performed on prenatal GBS isolates from penicillin-allergic women at high risk for anaphylaxis, as clindamycin resistance ranges from 3-15% among invasive GBS isolates. 6, 7, 9

Critical Clinical Pitfalls to Avoid

• Never treat GBS colonization with oral or IV antibiotics before labor, as such treatment is ineffective in eliminating carriage, does not prevent neonatal disease, and may cause adverse consequences including antibiotic resistance. 1, 6
• Women with GBS bacteriuria at any concentration during pregnancy require both treatment of the UTI and intrapartum prophylaxis during labor, as treating the UTI does not eliminate GBS colonization from the genitourinary tract. 6
• The designation of infants exposed to fewer than 4 hours of prophylaxis as particularly at risk for GBS sepsis may be pharmacokinetically inaccurate, as short durations achieve levels significantly above the MIC. 5
• Healthy-appearing infants >38 weeks' gestation whose mothers received >4 hours of intrapartum antibiotic prophylaxis may be discharged as early as 24 hours after delivery if other discharge criteria are met and appropriate home observation is available. 2

Pregnancy Safety Profile

• Reproduction studies in mice, rats, and rabbits have revealed no evidence of impaired fertility or harm to the fetus due to penicillin G. 8
• Human experience with penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus, though no adequate and well-controlled studies in pregnant women exist. 8
• Penicillins are excreted in human milk, and caution should be exercised when administered to nursing women. 8